Introduction: Somatostatin analogs are used for control of symptoms due to hormonal hypersecretion by neuroendocrine neoplasms (NEN). Their antiproliferative effect only recently became evident. Data on pancreatic NEN (pNEN) are limited.
Aim(s): We present patients with pNEN that received Lanreotide.
Materials and methods: 2 case reports
Conference: 12th Annual ENETS Conference 2015 (2015)
Category: Clinical cases/reports
Presenting Author: Michael Vaslamatzis
To read results and conclusion, please login ...
Further abstracts you may be interested in